BioMérieux S.A.
BIM
주식 순위
#1760
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
주가
$103.91
시가총액
$12.23B
변동 (1일)
0.86%
변동 (1년)
-19.74%
국가
FR
거래 BioMérieux S.A. (BIM)
카테고리
Healthcare
BioMérieux S.A. (BIM)의 P/S 비율
October 2026 기준 P/S 비율 TTM: 2.53
BioMérieux S.A.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 2.53입니다. 2023년 말 기준 P/S 비율은 3.23였습니다.
BioMérieux S.A.의 P/S 비율 기록 (2005 ~ 2026)
매년 말 P/S 비율
| 연도 | P/S 비율 | 변화 |
|---|---|---|
| 2026 (TTM) | 2.53 | -17.45% |
| 2024 | 3.06 | -5.24% |
| 2023 | 3.23 | 0.44% |
| 2022 | 3.22 | -26.45% |
| 2021 | 4.38 | 0.06% |
| 2020 | 4.37 | 24.59% |
| 2019 | 3.51 | 25.46% |
| 2018 | 2.80 | -26.81% |
| 2017 | 3.82 | 43.98% |
| 2016 | 2.65 | 20.26% |
| 2015 | 2.21 | 10.85% |
| 2014 | 1.99 | 4.99% |
| 2013 | 1.90 | 4.92% |
| 2012 | 1.81 | 18.41% |
| 2011 | 1.53 | -28.88% |
| 2010 | 2.15 | -18.52% |
| 2009 | 2.63 | 23.58% |
| 2008 | 2.13 | -27.38% |
| 2007 | 2.94 | 49.35% |
| 2006 | 1.97 | 11.04% |
| 2005 | 1.77 | 0.00% |
유사 기업 또는 경쟁사의 P/S 비율
| 회사 | P/S 비율 | P/S 비율 차이 | 국가 |
|---|---|---|---|
| 5.37 | 112.66% |
US
|
|
| 6.29 | 149.09% |
US
|
|
| 21.02 | 732.12% |
US
|
|
| - | - |
CN
|
|
| 6.67 | 163.90% |
US
|
